-
1
-
-
84860481791
-
ECRG4 is a novel inhibitor of Fas-induced apoptosis in human T-leukemia cells
-
Matsuzaki J, Torogoe T, Hirohashi Y etal. ECRG4 is a novel inhibitor of Fas-induced apoptosis in human T-leukemia cells. Carcinogenesis 2012; 33: 996-1003.
-
(2012)
Carcinogenesis
, vol.33
, pp. 996-1003
-
-
Matsuzaki, J.1
Torogoe, T.2
Hirohashi, Y.3
-
2
-
-
0031722319
-
Cloning and identification of cDNA fragments related to human esophageal cancer
-
in Chinese].
-
Su T, Liu H, Lu S. Cloning and identification of cDNA fragments related to human esophageal cancer. Zhonghua Zhong Liu Za Zhi 1998; 20: 254-257 [in Chinese].
-
(1998)
Zhonghua Zhong Liu Za Zhi
, vol.20
, pp. 254-257
-
-
Su, T.1
Liu, H.2
Lu, S.3
-
3
-
-
0037714882
-
Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma
-
Yue CM, Deng DJ, Bi MX, Guo LP, Lu SH. Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9: 1174-1178.
-
(2003)
World J Gastroenterol
, vol.9
, pp. 1174-1178
-
-
Yue, C.M.1
Deng, D.J.2
Bi, M.X.3
Guo, L.P.4
Lu, S.H.5
-
4
-
-
74249095339
-
ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma
-
Götze S, Feldhaus V, Traska T etal. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer 2009; 9: 447.
-
(2009)
BMC Cancer
, vol.9
, pp. 447
-
-
Götze, S.1
Feldhaus, V.2
Traska, T.3
-
5
-
-
67449097913
-
Hypermethylation of genes for diagnosis and risk stratification of prostate cancer
-
Vanaja DK, Ehrich M, Van den Boom D etal. Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Invest 2009; 27: 549-560.
-
(2009)
Cancer Invest
, vol.27
, pp. 549-560
-
-
Vanaja, D.K.1
Ehrich, M.2
Van den Boom, D.3
-
6
-
-
77954114174
-
Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion
-
Li W, Liu X, Zhang B etal. Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion. J Exp Clin Cancer Res 2010; 29: 1-7.
-
(2010)
J Exp Clin Cancer Res
, vol.29
, pp. 1-7
-
-
Li, W.1
Liu, X.2
Zhang, B.3
-
7
-
-
77952369496
-
Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells
-
Kujuro Y, Suzuki N, Kondo T. Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells. Proc Natl Acad Sci U S A 2010; 107: 8259-8264.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 8259-8264
-
-
Kujuro, Y.1
Suzuki, N.2
Kondo, T.3
-
8
-
-
68549103547
-
Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo
-
Li LW, Yu XY, Yang Y, Zhang CP, Guo LP, Lu SH. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo. Int J Cancer 2009; 125: 1505-1513.
-
(2009)
Int J Cancer
, vol.125
, pp. 1505-1513
-
-
Li, L.W.1
Yu, X.Y.2
Yang, Y.3
Zhang, C.P.4
Guo, L.P.5
Lu, S.H.6
-
9
-
-
0027292199
-
Establishment of apoptosis-inducing monoclonal antibody 2D1 and 2D1-resistant variants of human T cell lines
-
Takahashi S, Sato N, Takayama S etal. Establishment of apoptosis-inducing monoclonal antibody 2D1 and 2D1-resistant variants of human T cell lines. Eur J Immunol 1993; 23: 1935-1941.
-
(1993)
Eur J Immunol
, vol.23
, pp. 1935-1941
-
-
Takahashi, S.1
Sato, N.2
Takayama, S.3
-
10
-
-
65349106268
-
Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma
-
Inoda S, Hirohashi Y, Torigoe T etal. Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma. J Immunother 2009; 32: 474-485.
-
(2009)
J Immunother
, vol.32
, pp. 474-485
-
-
Inoda, S.1
Hirohashi, Y.2
Torigoe, T.3
-
11
-
-
28244490602
-
Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells
-
Asanuma H, Torigoe T, Kamiguchi K etal. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res 2005; 65: 11018-11025.
-
(2005)
Cancer Res
, vol.65
, pp. 11018-11025
-
-
Asanuma, H.1
Torigoe, T.2
Kamiguchi, K.3
-
12
-
-
38449122486
-
Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma
-
Mori Y, Ishiguro H, Kuwabara Y etal. Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncol Rep 2007; 18: 981-985.
-
(2007)
Oncol Rep
, vol.18
, pp. 981-985
-
-
Mori, Y.1
Ishiguro, H.2
Kuwabara, Y.3
-
13
-
-
79955698408
-
The prognostic effect of ethnicity for gastric and esophageal cancer: The population-based experience in British Columbia, Canada
-
Bashash M, Hislop TG, Shah AM, Le N, Brooks-Wilson A, Bajdik CD. The prognostic effect of ethnicity for gastric and esophageal cancer: The population-based experience in British Columbia, Canada. BMC Cancer 2011; 11: 164.
-
(2011)
BMC Cancer
, vol.11
, pp. 164
-
-
Bashash, M.1
Hislop, T.G.2
Shah, A.M.3
Le, N.4
Brooks-Wilson, A.5
Bajdik, C.D.6
-
14
-
-
84857422423
-
Ethnic differences in survival after breast cancer in South East Asia
-
Bhoo-Pathy N, Hartman M, Yip CH etal. Ethnic differences in survival after breast cancer in South East Asia. PLoS One 2012; 7: e30995.
-
(2012)
PLoS One
, vol.7
-
-
Bhoo-Pathy, N.1
Hartman, M.2
Yip, C.H.3
|